Targeted Delivery of Chemotherapy With Ultrasound and Microbublles
Targeted Delivery of Chemotherapy With Ultrasound and Microbubbles
Sponsor: University Hospital, Tours
Listed as NCT03458975, this PHASE2 trial focuses on Colorectal Cancer and Hepatic Metastases and remains completed. Sponsored by University Hospital, Tours, it has been updated 10 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Jun 2022 — Feb 2023 [monthly]
Recruiting PHASE2
-
Sep 2021 — Jun 2022 [monthly]
Recruiting PHASE2
▶ Show 5 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Feb 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Tours
For direct contact, visit the study record on ClinicalTrials.gov .